To demonstrate that the lack of activation of TILs in LY6G6D negative tumors is due to the absence of target expression, we incubated one of the CRC samples with an EpCAM/CD3 TcE as all the selected tumors expressed EpCAM. The gene discussed is EPCAM; the disease is colorectal carcinoma.